Opioid Maintenance Treatment as a Harm Reduction Tool for Opioid-Dependent Individuals in New York City: The Need to Expand Access to Buprenorphine/Naloxone in Marginalized Populations

REFERENCES

• Sullivan , L E and Fiellin , D A . 2008 . Narrative review: buprenorphine for opioid-dependent patients in office practice . Ann Intern Med , 148 : 662 – 70 .
   PubMed Web of Science ®Google Scholar
• Friedman , S R , Tempalski , B Cooper , H . 2004 . Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users . J Urban Health , 81 : 377 – 400 .
   PubMed Web of Science ®Google Scholar
• Peterson , J A , Schwartz , R P Mitchell , S G . 2010 . Why don't out-of-treatment individuals enter methadone treatment programmes? . Int J Drug Policy , 21 : 36 – 42 .
   PubMed Web of Science ®Google Scholar
• Kraus , M L , Alford , D P Kotz , M M . 2011 . Statement of the American Society of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction . J Addict Med , 5 : 254 – 63 .
   PubMed Web of Science ®Google Scholar
• Ducharme , L J and Abraham , A J . 2008 . State policy influence on the early diffusion of buprenorphine in community treatment programs . Subst Abuse Treat Prev Policy , 3 : 17
   PubMed Web of Science ®Google Scholar
• Stein , B D , Gordon , A J , Sorbero , M , Dick , A W , Schuster , J and Farmer , C . 2011 . The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: Recent service utilization trends in the use of buprenorphine and methadone . Drug Alcohol Depend ,
   Web of Science ®Google Scholar
• Sohler , N L , Li , X Kunins , H V . 2010 . Home- versus office-based buprenorphine inductions for opioid-dependent patients . J Subst Abuse Treat , 38 : 153 – 9 .
   PubMed Web of Science ®Google Scholar
• Hersh , D , Little , S L and Gleghorn , A . 2011 . Integrating buprenorphine treatment into a public healthcare system: the San Francisco Department of Public Health's office-based Buprenorphine Pilot Program . J Psychoactive Drugs , 43 : 136 – 45 .
   PubMed Web of Science ®Google Scholar
• Alford , D P , LaBelle , C T Richardson , J M . 2007 . Treating homeless opioid dependent patients with buprenorphine in an office-based setting . J Gen Intern Med , 22 : 171 – 6 .
   PubMed Web of Science ®Google Scholar
• Carrieri , M P , Amass , L , Lucas , G M , Vlahov , D , Wodak , A and Woody , G E . 2006 . Buprenorphine use: the international experience . Clin Infect Dis , 43 : S197 – S215 .
   PubMed Web of Science ®Google Scholar
• Emmanuelli , J and Desenclos , J C . 2005 . Harm reduction interventions, behaviours and associated health outcomes in France, 1996–2003 . Addiction , 100 : 1690 – 700 .
   PubMed Web of Science ®Google Scholar
• Auriacombe , M , Fatseas , M , Dubernet , J , Daulouede , J P and Tignol , J . 2004 . French field experience with buprenorphine . Am J Addict , 13 : S17 – S28 .
   PubMed Web of Science ®Google Scholar
• Moatti , J P , Carrieri , M P , Spire , B , Gastaut , J A , Cassuto , J P and Moreau , J . 2000 . Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment . The Manif 2000 study group. Aids , 14 : 151 – 5 .
   Google Scholar
• Roux , P , Carrieri , M P Cohen , J . 2009 . Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment . Clin Infect Dis , 49 : 1433 – 40 .
   PubMed Web of Science ®Google Scholar
• Comer , S D , Sullivan , M A Vosburg , S K . 2010 . Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers . Addiction , 105 : 709 – 18 .
   PubMed Web of Science ®Google Scholar
• Rosenheck , R and Kosten , T . 2001 . Buprenorphine for opiate addiction: potential economic impact . Drug Alcohol Depend , 63 : 253 – 62 .
   PubMed Web of Science ®Google Scholar
• King , V L , Burke , C Stoller , K B . 2008 . Implementing methadone medical maintenance in community-based clinics: disseminating evidence-based treatment . J Subst Abuse Treat , 35 : 312 – 21 .
   PubMed Web of Science ®Google Scholar
• Bell , J , Burrell , T , Indig , D and Gilmour , S . 2006 . Cycling in and out of treatment; participation in methadone treatment in NSW, 1990–2002 . Drug Alcohol Depend , 81 : 55 – 61 .
   PubMed Web of Science ®Google Scholar
• Amodeo , M , Lundgren , L , Chassler , D and Witas , J . 2008 . High-frequency users of detoxification: who are they? . Subst Use Misuse , 43 : 839 – 49 .
   PubMed Web of Science ®Google Scholar
• Roux , P , Tindall , C Fugon , L . 2012 . Impact of inpatient research participation on subsequent heroin use patterns: Implications for ethics and public health . Addiction , 107 ( 3 ) : 642 – 9 .
   PubMed Web of Science ®Google Scholar
• Bernstein , E , Bernstein , J Tassiopoulos , K . 2005 . Racial and ethnic diversity among a heroin and cocaine using population: treatment system utilization . J Addict Dis , 24 : 43 – 63 .
   PubMed Web of Science ®Google Scholar
• Bourgois , P , Martinez , A , Kral , A , Edlin , B R , Schonberg , J and Ciccarone , D . 2006 . Reinterpreting ethnic patterns among white and African American men who inject heroin: a social science of medicine approach . PLoS Med , 3 : e452
   PubMed Web of Science ®Google Scholar
• Perreault , M , Rousseau , M , Mercier , C , Lauzon , P , Gagnon , C and Cote , P . 2003 . Accessibility to methadone substitution treatment: the role of a low-threshold program . Can J Public Health , 94 : 197 – 200 .
   PubMed Web of Science ®Google Scholar
• Spire , B , Lucas , G M and Carrieri , M P . 2007 . Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST) . Int J Drug Policy , 18 : 262 – 70 .
   PubMed Web of Science ®Google Scholar
• Sullivan , L E and Fiellin , D A . 2005 . Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence . Clin Infect Dis , 41 : 891 – 6 .
   PubMed Web of Science ®Google Scholar
• Gossop , M , Marsden , J , Stewart , D and Rolfe , A . 1999 . Treatment retention and 1 year outcomes for residential programmes in England . Drug Alcohol Depend , 57 : 89 – 98 .
   PubMed Web of Science ®Google Scholar
• Roux , P , Villes , V Blanche , J . 2008 . Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management . Drug Alcohol Depend , 97 : 105 – 13 .
   PubMed Web of Science ®Google Scholar
• Dasgupta , N , Bailey , E J Cicero , T . 2010 . Post-marketing surveillance of methadone and buprenorphine in the United States . Pain Med , 11 : 1078 – 91 .
   PubMed Web of Science ®Google Scholar
• Feroni , I , Peretti-Watel , P Paraponaris , A . 2005 . French general practitioners’ attitudes and prescription patterns toward buprenorphine maintenance treatment: does doctor shopping reflect buprenorphine misuse? . J Addict Dis , 24 : 7 – 22 .
   PubMed Web of Science ®Google Scholar
• Mammen , K and Bell , J . 2009 . The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence . Expert Opin Pharmacother , 10 : 2537 – 44 .
   PubMed Web of Science ®Google Scholar
• Bruce , R D , Govindasamy , S , Sylla , L , Kamarulzaman , A and Altice , F L . 2009 . Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market . Am J Drug Alcohol Abuse , 35 : 68 – 72 .
   PubMed Web of Science ®Google Scholar
• Wesson , D R and Smith , D E . 2010 . Buprenorphine in the treatment of opiate dependence . J Psychoactive Drugs , 42 : 161 – 75 .
   PubMed Web of Science ®Google Scholar
• Cicero , T J , Inciardi , J A and Munoz , A . 2005 . Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002–2004 . J Pain , 6 : 662 – 72 .
   PubMed Web of Science ®Google Scholar
• Gwin Mitchell , S , Kelly , S M Brown , B S . 2009 . Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland . Am J Addict , 18 : 346 – 55 .
   PubMed Web of Science ®Google Scholar
• Bazazi , A R , Yokell , M , Fu , J J , Rich , J D and Zaller , N D . 2011 . Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users . J Addict Med , 5 : 175 – 80 .
   PubMed Web of Science ®Google Scholar
• Ompad , D C , Fuller , C M , Chan , C A , Frye , V , Vlahov , D and Galea , S . 2008 . Correlates of illicit methadone use in New York City: a cross-sectional study . BMC Public Health , 8 : 375
   PubMed Web of Science ®Google Scholar